Agenda | Board Governance Committee (BGC) | 2 November 2016

1. Approval of Minutes (18 October 2016)
2. Reconsideration Request 16-13: Merck KGaA (merck.pharmacy)
3. Discussion of Committee Slating
4. Discussion of Reconsideration Process Under New Bylaws
5. Board Member Skill Sets - Guidance to Nominating Committee
6. Discussion of Transparency Process for Committees
7. Officers and Board Members Statements of Interest Summary
8. Code of Conduct Annual Report
9. Accountability Mechanism Annual Report
10. Status of Pending Independent Review Process Proceedings
11. Any Other Business

Published on 27 October 2016